Your session is about to expire
← Back to Search
Morphine for Postoperative Pain
Study Summary
This trial will study whether increasing compliance with electronic order-sets and focused education will decrease the amount of unconsumed opioids in the home following pediatric supracondylar fracture repair.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2015 Phase 4 trial • 84 Patients • NCT02009722Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Split Script
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Which individuals are eligible to partake in this trial?
"This research is searching for 175 participants with pain, postoperative aged 1 Month to 18. In order to qualify, candidates must possess Type II or Type III supracondylar fractures and be undergoing a surgery that involves wire placement or pinning. Furthermore, they should plan on returning to the fracture clinic three weeks after their procedure in order to have pins/wires removed."
Has recruitment for this clinical trial commenced?
"Per the information available on clinicaltrials.gov, this research program is no longer looking for participants; however, there are currently 484 other trials in progress that need volunteers. This study was first posted on July 1st 2022 and last revised on May 11th 2022."
Is the eligibility threshold for this clinical trial restricted to those who are under sixty years of age?
"To qualify for this trial, participants must be between one month and eighteen years old."
Share this study with friends
Copy Link
Messenger